Suppr超能文献

2型原发性高草酸尿症的迟发性视网膜草酸沉着症

Late-onset retinal oxalosis in primary hyperoxaluria type 2.

作者信息

Bhuyan Rupak, Maggio Tyler, Thomas Christie, Sambharia Meenakshi, Gehrs Karen, Boyce Timothy

机构信息

Department of Ophthalmology and Visual Sciences, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA, 52242, USA.

Department of Internal Medicine, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA, 52242, USA.

出版信息

Am J Ophthalmol Case Rep. 2024 Aug 22;36:102156. doi: 10.1016/j.ajoc.2024.102156. eCollection 2024 Dec.

Abstract

PURPOSE

To report a previously undescribed case of late-onset vision loss due to retinal oxalosis in a patient with primary hyperoxaluria type 2 (PH2).

OBSERVATIONS

An 82-year-old female with a history of biopsy-proven oxalate nephropathy developed vision loss 8 months after end stage kidney disease. She developed progressive retinal ischemia secondary to crystal deposition. She was presumed to have retinal oxalosis, and genetic testing confirmed PH2. Her retinopathy occurred once renal clearance fellow below hepatic oxalate production. The only effective treatment is kidney transplantation, but this patient was not a candidate.

CONCLUSIONS AND IMPORTANCE

To date, this is the most delayed-onset and severe reported case of progressive ischemic retinopathy from PH2. Patients with systemic oxalosis should be referred for genetic testing, as there are new RNA interference treatments approved for other subtypes of primary hyperoxaluria.

摘要

目的

报告1例2型原发性高草酸尿症(PH2)患者因视网膜草酸沉着症导致迟发性视力丧失的此前未描述的病例。

观察结果

一名82岁女性,有经活检证实的草酸肾病病史,在终末期肾病8个月后出现视力丧失。她因晶体沉积继发进行性视网膜缺血。推测她患有视网膜草酸沉着症,基因检测证实为PH2。她的视网膜病变发生在肾脏清除率低于肝脏草酸生成量之时。唯一有效的治疗方法是肾移植,但该患者不适合。

结论与重要性

迄今为止,这是报道的PH2所致进行性缺血性视网膜病变中发病最延迟且最严重的病例。系统性草酸沉着症患者应转诊进行基因检测,因为有新的RNA干扰疗法已被批准用于原发性高草酸尿症的其他亚型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49c8/11395740/65d3ea510a75/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验